df-1001
dragonfly
['dragon']
dragonfly therapeutics to present phase 1 df1001 monotherapy ... - pr newswire 
PepVax is developing DNA-based drug delivery and development platform called SMARTmid™ Technology to manufacture treatments inside patients (Intusic™)